Adaptive Biotechnologies
ADPT
#4426
Rank
A$3.43 B
Marketcap
A$22.47
Share price
-4.25%
Change (1 day)
76.20%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: A$3.43 Billion

As of February 2026 Adaptive Biotechnologies has a market cap of A$3.43 Billion. This makes Adaptive Biotechnologies the world's 4426th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.43 B-9.89%
2025A$3.80 B155.05%
2024A$1.49 B43.33%
2023A$1.04 B-35.15%
2022A$1.60 B-70.61%
2021A$5.46 B-48.06%
2020A$10.51 B96.52%
2019A$5.35 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

A$3.43 Billion
by Nasdaq info icon info icon
A$3.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
A$167.24 B 4,776.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
A$3.32 B-2.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
A$0.62 B-81.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
A$2.77 B-19.20%๐Ÿ‡บ๐Ÿ‡ธ USA